Which has better earnings and valuation, HTFL or WAY?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $212.07M 20.50 -$116.79M -$1.83 N/A Waystar $1.10B 4.49 $112.09M $0.70 36.74

Is HTFL or WAY more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Waystar 11.18% 7.03% 4.75%

Does the media refer more to HTFL or WAY?

In the previous week, Waystar had 3 more articles in the media than Heartflow. MarketBeat recorded 16 mentions for Waystar and 13 mentions for Heartflow. Heartflow's average media sentiment score of 1.29 beat Waystar's score of 0.85 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has better earnings and valuation, DOCS or HTFL?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.28 $196.05M $0.85 30.97 Heartflow $212.07M 20.50 -$116.79M -$1.83 N/A

Is DOCS or HTFL more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Heartflow -55.82% -23.52% -18.66%

Does the media prefer DOCS or HTFL?

In the previous week, Heartflow had 3 more articles in the media than Doximity. MarketBeat recorded 13 mentions for Heartflow and 10 mentions for Doximity. Heartflow's average media sentiment score of 1.29 beat Doximity's score of 0.58 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, HTFL or SDGR?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $212.07M 20.50 -$116.79M -$1.83 N/A Schrodinger $255.87M 6.02 -$103.26M -$0.74 N/A

Is HTFL or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer HTFL or SDGR?

In the previous week, Heartflow had 4 more articles in the media than Schrodinger. MarketBeat recorded 13 mentions for Heartflow and 9 mentions for Schrodinger. Heartflow's average media sentiment score of 1.29 beat Schrodinger's score of 1.23 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, HTFL or CERT?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $212.07M 20.50 -$116.79M -$1.83 N/A Certara $418.84M 3.02 -$1.60M -$0.45 N/A

Is HTFL or CERT more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Certara -16.75% 3.86% 2.65%

Does the media refer more to HTFL or CERT?

In the previous week, Heartflow had 9 more articles in the media than Certara. MarketBeat recorded 13 mentions for Heartflow and 4 mentions for Certara. Certara's average media sentiment score of 1.55 beat Heartflow's score of 1.29 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Certara 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has higher earnings and valuation, GDRX or HTFL?

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.48 $30.44M $0.04 86.25 Heartflow $212.07M 20.50 -$116.79M -$1.83 N/A

Is GDRX or HTFL more profitable?

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Heartflow -55.82% -23.52% -18.66%

Does the media prefer GDRX or HTFL?

In the previous week, Heartflow had 10 more articles in the media than GoodRx. MarketBeat recorded 13 mentions for Heartflow and 3 mentions for GoodRx. Heartflow's average media sentiment score of 1.29 beat GoodRx's score of 0.13 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Heartflow 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Heartflow (HTFL) Competitors

$50.00 -0.43 (-0.85%)

Closing price 09/2/2026 04:00 PM Eastern

Extended Trading

$49.36 -0.64 (-1.28%)

As of 09/2/2026 07:30 PM Eastern

Compare

HTFL vs. WAY, DOCS, SDGR, CERT, and GDRX

Should you buy Heartflow stock or one of its competitors? Heartflow's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Heartflow compare to Waystar?

Heartflow (NASDAQ:HTFL) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07M	20.50	-$116.79M	-$1.83	N/A
Waystar	$1.10B	4.49	$112.09M	$0.70	36.74

In the previous week, Waystar had 3 more articles in the media than Heartflow. MarketBeat recorded 16 mentions for Waystar and 13 mentions for Heartflow. Heartflow's average media sentiment score of 1.29 beat Waystar's score of 0.85 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	7 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Heartflow currently has a consensus target price of $43.43, suggesting a potential downside of 13.14%. Waystar has a consensus target price of $35.52, suggesting a potential upside of 38.11%. Given Waystar's stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Waystar	1 Sell rating(s)	2 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Waystar	11.18%	7.03%	4.75%

Summary

Waystar beats Heartflow on 12 of the 14 factors compared between the two stocks.

How does Heartflow compare to Doximity?

Doximity (NYSE:DOCS) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends.

87.2% of Doximity shares are owned by institutional investors. 31.8% of Doximity shares are owned by insiders. Comparatively, 7.7% of Heartflow shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Heartflow	-55.82%	-23.52%	-18.66%

Doximity currently has a consensus price target of $32.43, indicating a potential upside of 23.18%. Heartflow has a consensus price target of $43.43, indicating a potential downside of 13.14%. Given Doximity's higher possible upside, research analysts plainly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.28	$196.05M	$0.85	30.97
Heartflow	$212.07M	20.50	-$116.79M	-$1.83	N/A

In the previous week, Heartflow had 3 more articles in the media than Doximity. MarketBeat recorded 13 mentions for Heartflow and 10 mentions for Doximity. Heartflow's average media sentiment score of 1.29 beat Doximity's score of 0.58 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Doximity beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Heartflow compare to Schrodinger?

Heartflow (NASDAQ:HTFL) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

In the previous week, Heartflow had 4 more articles in the media than Schrodinger. MarketBeat recorded 13 mentions for Heartflow and 9 mentions for Schrodinger. Heartflow's average media sentiment score of 1.29 beat Schrodinger's score of 1.23 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Heartflow currently has a consensus price target of $43.43, suggesting a potential downside of 13.14%. Schrodinger has a consensus price target of $20.50, suggesting a potential downside of 1.82%. Given Schrodinger's higher possible upside, analysts plainly believe Schrodinger is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07M	20.50	-$116.79M	-$1.83	N/A
Schrodinger	$255.87M	6.02	-$103.26M	-$0.74	N/A

79.1% of Schrodinger shares are held by institutional investors. 7.7% of Heartflow shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Schrodinger	-20.98%	-16.37%	-8.19%

Summary

Schrodinger beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Heartflow compare to Certara?

Heartflow (NASDAQ:HTFL) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, Heartflow had 9 more articles in the media than Certara. MarketBeat recorded 13 mentions for Heartflow and 4 mentions for Certara. Certara's average media sentiment score of 1.55 beat Heartflow's score of 1.29 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07M	20.50	-$116.79M	-$1.83	N/A
Certara	$418.84M	3.02	-$1.60M	-$0.45	N/A

74.0% of Certara shares are held by institutional investors. 7.7% of Heartflow shares are held by insiders. Comparatively, 1.1% of Certara shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Certara	-16.75%	3.86%	2.65%

Heartflow presently has a consensus target price of $43.43, suggesting a potential downside of 13.14%. Certara has a consensus target price of $8.28, suggesting a potential downside of 0.03%. Given Certara's higher possible upside, analysts clearly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

Certara beats Heartflow on 10 of the 15 factors compared between the two stocks.

How does Heartflow compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Heartflow	-55.82%	-23.52%	-18.66%

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.25
Heartflow	$212.07M	20.50	-$116.79M	-$1.83	N/A

63.8% of GoodRx shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 7.7% of Heartflow shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Heartflow had 10 more articles in the media than GoodRx. MarketBeat recorded 13 mentions for Heartflow and 3 mentions for GoodRx. Heartflow's average media sentiment score of 1.29 beat GoodRx's score of 0.13 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Heartflow	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

GoodRx currently has a consensus price target of $4.23, indicating a potential upside of 22.53%. Heartflow has a consensus price target of $43.43, indicating a potential downside of 13.14%. Given GoodRx's higher probable upside, equities research analysts clearly believe GoodRx is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Heartflow	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Summary

GoodRx beats Heartflow on 9 of the 16 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.39B	$1.75B	$7.20B	$12.67B
Dividend Yield	N/A	4.70%	2.53%	8.56%
P/E Ratio	-27.32	21.36	272.64	25.23
Price / Sales	20.50	82.41	628.85	105.04
Price / Cash	N/A	31.85	76.98	52.08
Price / Book	15.53	7.16	12.85	6.10
Net Income	-$116.79M	-$26.60M	$3.47B	$348.86M
7 Day Performance	3.95%	-0.10%	-0.12%	-1.90%
1 Month Performance	86.85%	12.26%	6.74%	1.96%
1 Year Performance	59.85%	-15.21%	25.05%	15.30%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	2.1885 of 5 stars	$50.00 -0.9%	$43.43 -13.1%	+60.5%	$4.39B	$212.07M	N/A	699	Positive News
WAY Waystar	4.4449 of 5 stars	$25.25 +4.5%	$35.39 +40.2%	-30.6%	$4.84B	$1.21B	36.07	1,700	Analyst Forecast
DOCS Doximity	4.7132 of 5 stars	$25.60 +3.5%	$32.43 +26.7%	N/A	$4.56B	$644.86M	30.12	890
SDGR Schrodinger	1.143 of 5 stars	$20.41 +4.8%	$20.50 +0.4%	+9.3%	$1.51B	$259.04M	N/A	790	Positive News
CERT Certara	1.753 of 5 stars	$8.41 +2.3%	$8.28 -1.6%	-22.3%	$1.28B	$421.75M	N/A	1,576	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors